InSilico Medicine
Develops an AI platform for drug development to treat cancer and age-related diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.0b (Public information from Aug 2022)
Yuen Long District New Territories (HQ)
Authorizing premium user...